Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Gandeeva Therapeutics | 2022 | Series A | $40.0M | Vancouver |
| Mahana Therapeutics | 2022 | Non Equity Assistance | Undisclosed | San Francisco |
| Oasis Labs | 2022 | Series Unknown | Undisclosed | San Francisco |
| Decent | 2021 | Series A | $1.0M | San Francisco |
| Buf | 2021 | Series B | $68.0M | Toronto |
| Bild | 2021 | Seed | $3.0M | San Francisco |
| Clarifai | 2021 | Series C | $60.0M | Fort Lee |
| Science 37 | 2021 | Post Ipo Equity | $200.0M | Culver City |
| Copia Automation | 2021 | Series A | $14.2M | New York |
| AllStripes | 2021 | Series B | $50.0M | San Francisco |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 351 | Gandeeva Therapeutics | Series A | $40.0M | Vancouver, Canada |
| 352 | Mahana Therapeutics | Non Equity Assistance | Undisclosed | San Francisco, United States |
| 353 | Oasis Labs | Series Unknown | Undisclosed | San Francisco, United States |
| 354 | Decent | Series A | $1.0M | San Francisco, United States |
| 355 | Buf | Series B | $68.0M | Toronto, Canada |
| 356 | Bild | Seed | $3.0M | San Francisco, United States |
| 357 | Clarifai | Series C | $60.0M | Fort Lee, United States |
| 358 | Science 37 | Post Ipo Equity | $200.0M | Culver City, United States |
| 359 | Copia Automation | Series A | $14.2M | New York, United States |
| 360 | AllStripes | Series B | $50.0M | San Francisco, United States |
Gandeeva’s proprietary platform provides a rational, cryo-EM- and AI-driven approach for the design of potent molecular glues.
Mahana Therapeutics is a developer of digital treatments for people living with gastrointestinal conditions.
Oasis Labs is a privacy-first cloud computing platform on blockchain technology.
Decent offers affordable healthcare by aligning incentives to improve health, reduce costs, and put members at the center of their care.
Buf is building tools to help companies completely change the way they work with APIs throughout their lifecycle.
Build hardware faster. better. together.
Clarifai's platform supports the full AI development lifecycle; including dataset preparation, model training and deployment.
Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
Copia automation brings DevOps tools to industrial automation.
AllStripes is a healthcare technology company that accelerates drug development and research for the treatment of rare diseases.
Hailify is a logistics company offering a B2B dispatch software solution to scale delivery operations.
HiHello is a software company that builds next generation professional network that allows people to optimize their business relationships.
Cape Analytics provides AI and analytics services for properties.
Caper builds autonomous retailer devices and solutions powered by deep learning and computer vision
Upward Farms grows high ecological and quality standard leafy greens and fish to nourish people, families, and the planet.
Super is an insurtech company that offers a subscription service for home care and repair.
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Multiply Labs deploys advanced robotics technology to manufacture personalized pharmaceutical capsules.
EverlyWell is a digital health company that offers consumer testing, virtual care, at-home collection tests, and digital results.
Plethora offers CNC machining services.
A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform
Zoox is an AI robotics company that provides mobility-as-a-service and self-driving car services.
Drone Racing League organizes global drone races featuring top pilots, streamed on various platforms.
Lightform designs hardware tools for projection.
Toonimo provides personalized & interactive guidance, with visual cues and a real human voice
Lux Capital has invested in 390 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Lux Capital's top investment sectors include Health Care, Artificial Intelligence (AI), Software, Biotechnology, Robotics. The firm invests across 70 different industry categories.
Among tracked funding rounds, Science 37 received $200.0M in a Post Ipo Equity round. Lux Capital's total known invested capital is $10.5B.
Lux Capital's average investment size is $49.1M across its portfolio of 390 companies.
Recent Lux Capital portfolio additions include Gandeeva Therapeutics, Mahana Therapeutics, Oasis Labs, Decent, Buf. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors